3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Colorectal Neoplasms
5
Stomach Neoplasms
4
Sarcoma
2
Endometrial Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Postoperative Complications
1
Ovarian Neoplasms
1
Neoplasms
1
Motor Activity
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Gynecologic Surgical Procedures
1
Gynecologic Cancer
1
Gastrointestinal Neoplasms
1
Frailty
1
Coma
1
Colonic Neoplasms
1
Cerebrovascular Disorders
1
Carcinoma, Hepatocellular
1
Brain Injuries, Traumatic
1
Interventions
Standard of Care
2
Brachytherapy
2
genexol-PM
1
gadobutrol
1
fosaprepitant
1
Surveys and Questionnaires
1
Sex
1
Radiotherapy, Intensity-Modulated
1
Psychotherapy
1
Prochlorperazine
1
Preoperative Exercise
1
Population Groups
1
Ondansetron
1
Olanzapine
1
Neurokinin-1 Receptor Antagonists
1
NK Cell Lectin-Like Receptor Subfamily B
1
Imagery, Psychotherapy
1
FloSeal Matrix
1
Ferric Oxide, Saccharated
1
Exercise
1
Enhanced Recovery After Surgery
1
Educational Status
1
Drug Therapy
1
Dexamethasone
1
Cryotherapy
1
Counseling
1
Cisplatin
1
Blood Specimen Collection
1
AGuIX
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Gynecologic Cancer
×
Enhanced Recovery After Surgery
×
Clear all
NCT04596800
2023-10-31
PROPER
Instituto Brasileiro de Controle do Cancer
Phase 3
Unknown
194 enrolled